Your browser doesn't support javascript.
loading
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11).
Chu, Li; Chen, Yun; Liu, Qi; Liang, Fei; Wang, Shengping; Liu, Quan; Yu, Hui; Wu, Xianghua; Zhang, Junhua; Deng, Jiaying; Ai, Dashan; Zhu, Zhengfei; Nie, Yongzhan; Zhao, Kuaile.
Afiliação
  • Chu L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Chen Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Liu Q; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Liang F; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Wang S; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Liu Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Yu H; Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wu X; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Zhang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Deng J; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Ai D; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Zhu Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Nie Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Zhao K; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Oncologist ; 26(6): e925-e935, 2021 06.
Article em En | MEDLINE | ID: mdl-33393167
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago / Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido